ixlayer

🔔 Join Us for an Insightful Webinar on Biopharma Direct-to-Patient Programs! 🔔 Register for our upcoming DHC Group Webinar with ixlayer on November 21st at 1:00pm ET to learn how to enhance patient experiences and drive better health outcomes through best practices in Direct-to-Patient (DTP) implementation. We’ll be debunking common DTP myths, sharing insider knowledge, and discussing: 🔹 Patient expectations and DTP's role in early intervention 🔹 A deep dive into telehealth, lab testing, and Rx fulfillment 🔹 Navigating compliance and complex options Register now! 👉https://lnkd.in/ezkCSC3j

A lot of amazing innovations and developments came out of #HLTHUSA this week. With so many of the brightest minds in health and tech represented, ixlayer is proud to have our Complete Blood Count (CBC) test with at-home sample collection for direct-to-patient biopharma programs featured in this trends-to-watch piece. Thanks so much to Beth Kutscher for including us! #HLTH #HLTHUSA2024 https://lnkd.in/dQ68TgSC

As an advisor at ixlayer, I’m excited about their launch of remote CBC testing (#HLTHUSA). Cutting-edge sample collection devices allow patients to use a simple-to-administer blood sample collection kit from the comfort of their home. This capability simplifies the process of obtaining essential medications, which require a CBC test prior to prescribing; resulting in personalized treatment plans, reducing hospitalizations, and ensuring timely interventions, particularly for those with limited access to healthcare facilities.

We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma programs through ixEngage. ixLayer is paving the future for at-home testing access for patients. “Remote CBC testing as part of ixEngage accelerates patient-centered healthcare,” explained Pouria Sanae, CEO and co-founder of ixlayer. “At ixlayer, we continually merge medical and technological innovations to shift the healthcare paradigm from reactive to proactive care so patients can get the care they want and need when it’s convenient for their schedules.” Congratulations! #HLTHUSA

We had a blast at The Sphere last night with Meghan Wetteland, Sara Weaver, Rob Moher, Keith McGee, Nandini Nayar, Mariano Bendersky, Elsa Rive Boukadoum, Eric McCulley, Marc Weiss, Dan Hoffman, Gati Dharani, Anuj Desai, Matthew Walsh, Misty McKay Burkhart, Drew Thimme, and Debra Harris. Looking forward to a great afternoon at #HLTHUSA! #HLTHUSA2024

Today at #HLTHUSA, ixlayer announced the availability of a Complete Blood Count (CBC) test with at-home sample collection for direct-to-patient biopharma programs through our DTP solution, ixEngage. ixEngage removes barriers to care by accelerating pre-treatment and routine CBC tests used for hundreds of conditions, including asthma, heart disease and kidney disease. #HLTH #HLTHUSA2024 Read the press release: https://lnkd.in/drrMBjjN

#HLTHUSA is almost here! Want to connect during the show? Send us a message at conferences@ixlayer.com. Whether it's at our private event hosted at the Sphere or over a cup of coffee at the conference, we're excited to share how ixlayer can support your biopharma direct-to-patient initiatives with our end-to-end platform. #Biopharma #Healthcare #HealthInnovation #FutureofHealth

Matthew Walsh, General Manager of Biopharma at ixlayer, sat down with #FiercePharma at #DigitalPharmaEast to discuss the exciting rise of direct-to-patient (DTP) services. With over 50% of pharmaceutical marketing executives planning to implement these services, Walsh sheds light on how this shift will revolutionize the way patients interact with healthcare and, critically, simplify the patient journey. #healthcareinnovations #pharmamarketing #directtopatient https://lnkd.in/ePafpHYA

We’re looking forward to attending HLTH USA and can’t wait for our upcoming private event hosted at the Sphere! Interested to learn how ixlayer can support your biopharma direct-to-patient initiatives with our end-to-end platform? Let’s connect during the show. Send us a message at conferences@ixlayer.com. #HLTHUSA #Biopharma #Healthcare #HealthInnovation #FutureofHealth

ixlayer is so happy to have participated in the The DHC Group's summit at GSK. ixlayer’s General Manager of Biopharma, Matthew Walsh engaged in an insightful discussion about the role tech plays in partnering with pharmaceutical companies to bring patient-centric experiences to the forefront of the healthcare experience. This was a great session that put forth valuable ideas about how direct-to-patient strategies are driving meaningful change in patient access, engagement and outcomes and can support commercial success. We’ll be recapping these insights in a forthcoming blog post. Stay tuned! #DHCSummit #digitalHealth #healthcareinnovation #pharmamarketing